2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile

CE Pharm Co.,Ltd founded in October 2018 with a registered capital of 100 million yuan, is a leading pharmaceutical enterprise jointly initiated and established by Shanghai Institute of Organic Chemistry and Lianhetech (stock code: 002250) which is a listed company. CE Pharm is mainly engaged in pharmaceutical intermediates and API R&D, production, sales.CE Pharm also provide pharmaceutical technology development, technology transfer and technical consulting service. Relying on the excellent innovation ability of Shanghai Institute of Organic Chemistry and the powerful production management platform of Lianhetech, the company is committed to becoming a first-class enterprise with innovation-driven core competitiveness. In order to better industrialize science and technology, the company established CE Pharm Shanghai R&D center , located in Zhoupu, Pudong, mainly engaged in innovative technology research on pharmaceutical intermediates and complex drug molecule.